Locations:
Search IconSearch
July 20, 2017/Cancer

New Findings: Influence of High-Fat Diet on Colorectal Cancer

Study uncovers key molecular pathways

17-DDI-3625-Colon-Cancer-CQD

Poor diet is associated with 80 percent of colorectal cancer cases, but the exact pathways by which diet leads to cancer are not known.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In a newly published study, Cleveland Clinic researchers have identified a specific molecular pathway that plays a key role in the link between a high-fat diet and tumor growth in the colon.

Study design

In the July 6 issue of Stem Cell Reports, the team showed that colon cancer stem cell growth in mice was enhanced by a high-fat, Western diet. Cancer stem cells are a subset of resilient, aggressive malignant cells that are believed to be partially responsible for spread and recurrence of cancer.

The researchers focused on the JAK2-STAT3 cellular signaling pathway, a widely studied pathway known to promote tumor growth. When the JAK2-STAT3 pathway was blocked, the spike in cancer stem cell growth caused by the high-fat diet declined, providing more insight into how this pathway is linked to diet-related cancer. Researchers anticipate that pinpointing the exact mechanism can lead to the development of therapeutics to counteract the negative effects of a Western diet on colorectal cancer.

Understanding the connection

“We have known the influence of diet on colorectal cancer. However, these new findings are the first to show the connection between high-fat intake and colon cancer via a specific molecular pathway,” says colorectal surgeon Matthew Kalady, MD, co-author of the study and Co-Director of the Cleveland Clinic Comprehensive Colorectal Cancer Program. “We can now build upon this knowledge to develop new treatments aimed at blocking this pathway and reducing the negative impact of a high-fat diet on colon cancer risk.”

Advertisement

The team analyzed human colorectal cancer-free survival data in the Cancer Genome Atlas and evaluated primary and metastasized colorectal cancer specimens via microarray analysis. They further verified the link between high-fat diet and stem cell maintenance in obesity-resistant mice.

“These findings also provide a new way in which cancer stem cells are regulated and provide insight into how environmental influences, such as diet, can alter cancer stem cell populations in advanced cancers,” says Justin D. Lathia, PhD, Associate Professor in the Lerner Research Institute’s Department of Cellular and Molecular Medicine and co-author of the study.

Senior author of the study was the late Noa Noy, PhD, and first author was Sheelarani Karunanithi, PhD. The laboratories of Ofer Reizes, PhD, Justin D. Lathia, PhD, and Dr. Kalady participated in the study. This work was supported by National Institute of Health grant R01DK088969.

Advertisement

Related Articles

Woman with breast cancer
January 2, 2025/Cancer/News & Insight
Real-World Insights of KEYNOTE-522 Regimen Adoption for Treating Triple-Negative Breast Cancer

Real-world results reporting aims to make treatments safer and more effective

DNA strand
December 31, 2024/Cancer/News & Insight
New Data Further Support Breast Cancer Polygenic Risk Score

Ongoing clinical validation in diverse populations refine breast cancer risk substratification

Dr. Dermawan
December 24, 2024/Cancer/News & Insight
New Genomic Models for Leiomyosarcoma Treatment (Podcast)

Soft tissue pathologist discusses research into incorporating genomic data to improve risk stratification

Dr. Shahzad Raza
December 18, 2024/Cancer/News & Insight
Researchers Explore Prognostic Value of Transcriptomic Data in Multiple Myeloma

Prediction and bioinformatic data could prove valuable for therapeutic interventions targeting this malignancy

3D rendering of bispecific antibodies
December 17, 2024/Cancer/Blood Cancers
Efficacy and Safety Outcomes of Bispecific Antibodies

Study measures real-world outcomes for relapsed or refractory large B-cell lymphoma

rendering of Doxorubicin molecules
December 13, 2024/Cancer/News & Insight
Research Offers Further Insight into Chemo Scheduling for Early Breast Cancer

Phase 3 trial found no survival differences between weekly or biweekly doxorubicin/cyclophosphamide or between weekly or biweekly paclitaxel

BRCA1 (3d structure)
December 12, 2024/Cancer/News & Insight
Risk-Reducing Surgeries Improve Survival for Younger BRCA Breast Cancer Patients

Findings strengthen evidence for risk-reducing procedures

Ad